Feature | Artificial Intelligence | March 01, 2019 | By Greg Freiherr

Entrepreneurs to pitch innovative ideas at ACC

ACC Future Hub

Presenter delivers pitch at last year’s ACC Future Hub. This year during ACC.19, entrepreneurs will pitch software and hardware specific to cardiology in two categories– artificial intelligence and digitally enabled medical devices. (Image courtesy of ACC)


Immersed in a Shark Tank-like atmosphere, entrepreneurs will pitch ideas for new technologies and services at ACC.19, this year’s annual meeting of the American College of Cardiology.

The first pitches will be delivered Sunday morning, March 17, beginning at 9:45 am for artificial intelligence (AI) applications in cardiology. A second wave will be tossed the next morning, also at 9:45 am, regarding digitally enabled medical devices. Panels of judges, along with an on-site audience and viewers on Facebook Live, will vote to determine the winner in each category.

The appeal of these challenges will be similar to what attracts viewers to the television show Shark Tank, said AI challenge moderator Andrew M. Freeman, M.D..

“You get people with very pointed and intense questions,” said Freeman, who moderated an “innovation challenge” at last year’s ACC meeting. The director of clinical cardiology at National Jewish Health, an academic hospital/clinic in Denver, compared his duties at this year’s AI challenge to those of a game show host. Primarily, he will try to engage the audience with presenters and keep pitches on schedule.

Freeman was chosen as a moderator, he said, partly for his experience moderating other ACC events, as well as for his passion about medical technology and interest in new ideas to manage cardiac patients. In his practice at National Jewish Health, Freeman integrates evidence-based medicine and plant-based diet, the latter of which has earned him the “Vegan Cardiologist” nickname.

 

Future Hub at ACC19 To Go Beyond Challenges

The challenges in these two categories — AI and digitally enabled devices — will highlight the ACC’s Future Hub, which aims “to inform, educate and inspire ACC.19 attendees by exposing them to the latest innovations in digital health, medical devices and big data,” according to its website. Presentations, including ones on the implications of technology for the doctor-patient relationship, will go on before and after the challenges.

Freeman described ACC’s Future Hub as a unique complement to the scientific sessions going on during the meeting: “I think if anyone is curious about the future of cardiology or medicine, it is certainly a way to get a glimpse of it.”

All Hub presenters will address how emerging technologies might transform cardiovascular practice. Kiosks located in the Future Hub Learning Destination (Expo Hall, #146) will provide individualized hands-on opportunities. The theater in the Hub, where the one-hour challenges will happen, will serve up TED-style talks; small panel discussions and debates on future-based issues; and exhibitor demonstrations.

 

In Search of Angel Investors

To host the challenges, ACC is partnering with AngelMD, self-described as “a healthcare investment community” that combines healthcare startups with physicians, investors, and industry “with the goal of creating successful outcomes.”

The winner of each challenge will be profiled on the AngelMD website. The exposure, Freeman said, could translate into “hundreds of thousands or even millions of dollars” in investments. Winners will also receive kiosk space at next year’s Future Hub; exhibit space at ACC20; and a commemorative plaque.

Last year Challenges featured eight finalists, each with fledgling but promising products or services. They were selected from more than 60 applications assessed by a committee of experts provided by AngelMD. A major criterion for selection was the likelihood of product success.

This year’s two challenges will focus either on AI-based software or digitally enabled hardware. Four finalists in each category will pitch their products or services. They were chosen by a review committee from “dozens of applications,” according to Freeman, who served on the committee.

 

Greg Freiherr is a contributing editor to Imaging Technology News (ITN). Over the past three decades, Freiherr has served as business and technology editor for publications in medical imaging, as well as consulted for vendors, professional organizations, academia, and financial institutions.

 

Editor's note: In preparation for the upcoming American College of Cardiology (ACC) Conference on March 17, contributing editor Greg Freiherr begins the show coverage with this an exclusive series of articles and podcasts. This is the first article in a series of three.

 

Related Content:

Future Hub Showcases Latest Innovations in CV Care; Home to ACC.18 Innovation Challenge 

ACC.19 Innovation Challenge Participants Announced 

 


Related Content

News | Cardiac Imaging

May 21, 2026 — A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s ...

Time May 22, 2026
arrow
News | X-Ray

May 21, 2026 — RADIN Health and AZmed have announced the expansion of their strategic partnership and enhance radiology ...

Time May 22, 2026
arrow
News | Digital Pathology

May 7, 2026 — Roche has entered into a definitive merger agreement to acquire PathAI, a U.S.-based company in digital ...

Time May 21, 2026
arrow
News | Computed Tomography (CT)

May 12, 2026 – Bracco Imaging S.p.A. has purchased a mobile photon-counting CT scanner from MARS Bioimaging to support ...

Time May 20, 2026
arrow
Feature | Enterprise Imaging | Kyle Hardner

For radiology departments, the imbalance between surging imaging volume and a shortage of trained radiologists is taking ...

Time May 20, 2026
arrow
News | Interventional Radiology

May 12, 2026 — Siemens Healthineers has received clearance from the Food and Drug Administration for six new systems in ...

Time May 12, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

May 11, 2026 – At the International Society for Magnetic Resonance in Medicine (ISMRM) 2026 Annual Meeting, GE ...

Time May 11, 2026
arrow
News | Radiopharmaceuticals and Tracers

May 7, 2026 — Bayer has announced positive topline results from the Phase III REVEAL study, an investigator-initiated ...

Time May 08, 2026
arrow
News | FDA

May 6, 2026 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time May 07, 2026
arrow
News | ASE

May 4, 2026 — The American Society of Echocardiography (ASE) has released a new guideline that provides guidance for ...

Time May 05, 2026
arrow
Subscribe Now